← Back to Analyst Consensus 
MDWD Buy
MediWound Ltd.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 17, 2026 (22 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 14, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| May 28, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| May 28, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Nov 21, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $36 | 44% |
| May 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $31 | 44% |
| Mar 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Feb 28, 2025 | Craig-Hallum | initiate | — → Buy | $39 | 54% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Nov 27, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Oct 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
| Aug 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
| Jul 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
| May 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
| Mar 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
| Jan 16, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $28 | 44% |
| Nov 22, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $26 | 44% |
| Sep 21, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $26 | 44% |
| Aug 17, 2023 | Oppenheimer | maintain | Outperform → Outperform | $36 | 52% |
| Aug 17, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $23 | 44% |
| May 31, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $63 | 52% |
| May 31, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $23 | 44% |
| Mar 17, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $23 | 44% |
| Jan 4, 2023 | HC Wainwright & Co. | maintain | — → Buy | $23 | 44% |
| Dec 30, 2022 | Cowen & Co. | maintain | — → Outperform | $25 | — |
| Dec 22, 2022 | Maxim Group | initiate | — → Buy | $25 | 42% |
| Dec 21, 2022 | Oppenheimer | maintain | — → Outperform | $63 | 52% |
| Nov 16, 2022 | HC Wainwright & Co. | maintain | — → Buy | $5.5 | 44% |
| May 18, 2022 | Wells Fargo | maintain | — → Overweight | $8 | 54% |
| Mar 21, 2022 | Aegis Capital | maintain | — → Buy | $7 | — |
| Aug 17, 2021 | Aegis Capital | maintain | — → Buy | $9 | — |
| Aug 11, 2021 | HC Wainwright & Co. | maintain | — → Buy | $6.5 | 44% |
| Mar 2, 2021 | Aegis Capital | initiate | — → Buy | $10 | — |
| Sep 23, 2020 | BTIG | initiate | — → Buy | $6 | 52% |
| Aug 5, 2019 | HC Wainwright & Co. | initiate | — → Buy | $5.5 | 44% |
| Mar 20, 2018 | Wells Fargo | maintain | Outperform → Outperform | $8 | 54% |
| Mar 20, 2018 | Oppenheimer | maintain | Outperform → Outperform | $12 | 52% |
| Sep 28, 2017 | Cowen & Co. | initiate | — → Outperform | $9 | — |
| Nov 28, 2016 | Aegis Capital | initiate | — → Buy | $11 | — |
| Aug 17, 2016 | Wells Fargo | initiate | — → Outperform | $0 | 54% |
| Jul 29, 2016 | Jefferies | maintain | — → Buy | $13 | 52% |
| Mar 23, 2016 | SunTrust Robinson Humphrey | initiate | — → Buy | $13 | — |
| Feb 3, 2016 | Jefferies | maintain | — → Buy | $15 | 52% |
| Jan 11, 2016 | Brean Capital | initiate | — → Buy | $20 | — |
| Jan 8, 2016 | Brean Capital | initiate | — → Buy | $20 | — |
| Feb 13, 2015 | Jefferies | maintain | — → Buy | $13 | 52% |
| Apr 16, 2014 | Oppenheimer | initiate | — → Outperform | $25 | 52% |
| Apr 14, 2014 | BMO Capital | initiate | — → Outperform | $20 | 53% |
| Apr 14, 2014 | Credit Suisse | initiate | — → Outperform | $18 | — |
Price Target Trend
May 7, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days